1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Acute Lymphoblastic Leukemia Market, By Type
5.1 Introduction
5.2 T-cell Lymphoblastic Leukemia
5.3 B-cell Acute Lymphoblastic Leukemia
5.4 Philadelphia Chromosome
5.5 Other Types
6 Global Acute Lymphoblastic Leukemia Market, By Treatment
6.1 Introduction
6.2 Radiation Therapy
6.3 Targeted Therapy
6.4 Immunotherapy
6.5 Bone Marrow Transplant
6.6 Chemotherapy
6.7 Stem Cell Transplantation
6.8 Other Treatments
7 Global Acute Lymphoblastic Leukemia Market, By Age Group
7.1 Introduction
7.2 Adults
7.3 Pediatrics
8 Global Acute Lymphoblastic Leukemia Market, By Route of Administration
8.1 Introduction
8.2 Injectable
8.3 Oral
9 Global Acute Lymphoblastic Leukemia Market, By Diagnosis
9.1 Introduction
9.2 Spinal Tap and Cerebrospinal Fluid (CSF) Analysis
9.3 Bone Marrow Aspiration and Biopsy
9.4 Immunophenotyping
9.5 Complete Blood Count (CBC) and Differential
9.6 Flow Cytometry
9.7 Polymerase Chain Reaction (PCR)
9.8 Next-Generation Sequencing (NGS)
9.9 Minimal Residual Disease (MRD) Testing
9.10 Other Diagnosis
10 Global Acute Lymphoblastic Leukemia Market, By End User
10.1 Introduction
10.2 Clinics
10.3 Hospitals
10.4 Retail Pharmacy
10.5 Other End Users
11 Global Acute Lymphoblastic Leukemia Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Amgen, Inc.
13.2 Bristol-Myers Squibb Company
13.3 Celgene Corporation
13.4 Jazz Pharmaceuticals
13.5 Erytech Pharma
13.6 GlaxoSmithKline Plc.
13.7 F. Hoffmann-La Roche Ltd.
13.8 Genzyme Corporation
13.9 GlaxoSmithKline Plc.
13.10 Kite Pharma, Inc.
13.11 Novartis AG
13.12 Pfizer Inc.
13.13 Sanofi
13.14 Leadiant Biosciences Inc.
13.15 Spectrum Pharmaceuticals Inc.
13.16 Thermo Fisher Scientific Inc.
13.17 Baxter International Inc.
List of Tables
Table 1 Global Acute Lymphoblastic Leukemia Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Acute Lymphoblastic Leukemia Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Acute Lymphoblastic Leukemia Market Outlook, By T-cell Lymphoblastic Leukemia (2021-2030) ($MN)
Table 4 Global Acute Lymphoblastic Leukemia Market Outlook, By B-cell Acute Lymphoblastic Leukemia (2021-2030) ($MN)
Table 5 Global Acute Lymphoblastic Leukemia Market Outlook, By Philadelphia Chromosome (2021-2030) ($MN)
Table 6 Global Acute Lymphoblastic Leukemia Market Outlook, By Other Types (2021-2030) ($MN)
Table 7 Global Acute Lymphoblastic Leukemia Market Outlook, By Treatment (2021-2030) ($MN)
Table 8 Global Acute Lymphoblastic Leukemia Market Outlook, By Radiation Therapy (2021-2030) ($MN)
Table 9 Global Acute Lymphoblastic Leukemia Market Outlook, By Targeted Therapy (2021-2030) ($MN)
Table 10 Global Acute Lymphoblastic Leukemia Market Outlook, By Immunotherapy (2021-2030) ($MN)
Table 11 Global Acute Lymphoblastic Leukemia Market Outlook, By Bone Marrow Transplant (2021-2030) ($MN)
Table 12 Global Acute Lymphoblastic Leukemia Market Outlook, By Chemotherapy (2021-2030) ($MN)
Table 13 Global Acute Lymphoblastic Leukemia Market Outlook, By Stem Cell Transplantation (2021-2030) ($MN)
Table 14 Global Acute Lymphoblastic Leukemia Market Outlook, By Other Treatments (2021-2030) ($MN)
Table 15 Global Acute Lymphoblastic Leukemia Market Outlook, By Age Group (2021-2030) ($MN)
Table 16 Global Acute Lymphoblastic Leukemia Market Outlook, By Adults (2021-2030) ($MN)
Table 17 Global Acute Lymphoblastic Leukemia Market Outlook, By Pediatrics (2021-2030) ($MN)
Table 18 Global Acute Lymphoblastic Leukemia Market Outlook, By Route of Administration (2021-2030) ($MN)
Table 19 Global Acute Lymphoblastic Leukemia Market Outlook, By Injectable (2021-2030) ($MN)
Table 20 Global Acute Lymphoblastic Leukemia Market Outlook, By Oral (2021-2030) ($MN)
Table 21 Global Acute Lymphoblastic Leukemia Market Outlook, By Diagnosis (2021-2030) ($MN)
Table 22 Global Acute Lymphoblastic Leukemia Market Outlook, By Spinal Tap and Cerebrospinal Fluid (CSF) Analysis (2021-2030) ($MN)
Table 23 Global Acute Lymphoblastic Leukemia Market Outlook, By Bone Marrow Aspiration and Biopsy (2021-2030) ($MN)
Table 24 Global Acute Lymphoblastic Leukemia Market Outlook, By Immunophenotyping (2021-2030) ($MN)
Table 25 Global Acute Lymphoblastic Leukemia Market Outlook, By Complete Blood Count (CBC) and Differential (2021-2030) ($MN)
Table 26 Global Acute Lymphoblastic Leukemia Market Outlook, By Flow Cytometry (2021-2030) ($MN)
Table 27 Global Acute Lymphoblastic Leukemia Market Outlook, By Polymerase Chain Reaction (PCR) (2021-2030) ($MN)
Table 28 Global Acute Lymphoblastic Leukemia Market Outlook, By Next-Generation Sequencing (NGS) (2021-2030) ($MN)
Table 29 Global Acute Lymphoblastic Leukemia Market Outlook, By Minimal Residual Disease (MRD) Testing (2021-2030) ($MN)
Table 30 Global Acute Lymphoblastic Leukemia Market Outlook, By Other Diagnosis (2021-2030) ($MN)
Table 31 Global Acute Lymphoblastic Leukemia Market Outlook, By End User (2021-2030) ($MN)
Table 32 Global Acute Lymphoblastic Leukemia Market Outlook, By Clinics (2021-2030) ($MN)
Table 33 Global Acute Lymphoblastic Leukemia Market Outlook, By Hospitals (2021-2030) ($MN)
Table 34 Global Acute Lymphoblastic Leukemia Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
Table 35 Global Acute Lymphoblastic Leukemia Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
